Related Experiment Video
Updated: Apr 19, 2026

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
Published on: July 1, 2020
Combat-Related Invasive Fungal Wound Infections
David R Tribble1, Carlos J Rodriguez2
1Infectious Disease Clinical Research Program, Preventive Medicine and Biometrics Department, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814-5119, USA.
Abstract:
Combat-related invasive fungal (mold) wound infections (IFIs) have emerged as an important and morbid complication following explosive blast injuries among military personnel. Similar to trauma-associated IFI cases among civilian populations, as in agricultural accidents and natural disasters, these infections occur in the setting of penetrating wounds contaminated by environmental debris. Specific risk factors for combat-related IFI include dismounted (patrolling on foot) blast injuries occurring mostly in southern Afghanistan, resulting in above knee amputations requiring resuscitation with large-volume blood transfusions. Diagnosis of IFI is based upon early identification of a recurrently necrotic wound following serial debridement and tissue-based histopathology examination with special stains to detect invasive disease. Fungal culture of affected tissue also provides supportive information. Aggressive surgical debridement of affected tissue is the primary therapy. Empiric antifungal therapy should be considered when there is a strong suspicion for IFI. Both liposomal amphotericin B and voriconazole should be considered initially for treatment since many of the cases involve not only Mucorales species but also Aspergillus or Fusarium spp., with narrowing of regimen based upon clinical mycology findings.
Insights
Invasive fungal wound infections (IFIs) are a serious complication of combat blast injuries, particularly in Afghanistan. Early diagnosis and aggressive treatment, including surgery and antifungal medications, are crucial for patient survival.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Military Medicine
Background:
- Combat-related invasive fungal wound infections (IFIs) are a significant cause of morbidity in military personnel following explosive blast injuries.
- These infections resemble trauma-associated IFIs in civilians, often occurring in penetrating wounds contaminated with environmental debris.
- Specific risk factors include dismounted blast injuries in Afghanistan, leading to amputations and requiring massive blood transfusions.
Purpose of the Study:
- To highlight the emergence and characteristics of combat-related IFIs.
- To outline diagnostic approaches for these challenging infections.
- To provide therapeutic recommendations for managing IFIs in military casualties.
Main Methods:
- Diagnosis relies on identifying recurrently necrotic wounds after debridement.
- Histopathology with special stains and fungal cultures of affected tissue are key diagnostic tools.
- Treatment involves aggressive surgical debridement and consideration of empiric antifungal therapy.
Main Results:
- Early identification of necrotic wounds and histopathological evidence are critical for diagnosing IFIs.
- Fungal cultures provide supportive diagnostic information.
- Treatment strategies emphasize surgical intervention and prompt antifungal administration.
Conclusions:
- Aggressive surgical debridement is the cornerstone of IFI management.
- Empiric antifungal therapy, including liposomal amphotericin B and voriconazole, is recommended upon suspicion.
- Treatment regimens should be tailored based on identified fungal species, such as Mucorales, Aspergillus, or Fusarium.
More Related Videos
Related Concept Videos
Antifungal Agents
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Group Zygomycota
Diabetic Foot Ulcer
Staphylococcal Skin Infections
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.

